EFDID: 241541EFD: View Filing

Issuer: Amalgam Rx, Inc. (0001667234) - D/A

Accession: 0001667234-19-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001667234
  • Entity Name:
    Amalgam Rx, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2016)
  • Address:
    1007 N. MARKET STREET
    SUITE 400
    WILMINGTON, DE 19801
  • Persons:
    Related Persons 2
    Ryan A Sysko
    Executive Officer, Director
    Sarwar Islam
    Director
EDGAR: Offering Information
  • Accession Date:
    03/05/2019
  • First Sale Date:
    06/16/2017
  • Offering Amount:
    $2,000,000
  • Amount Sold:
    $998,044
  • Amount Remaining:
    $1,001,956
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, DE, MD, NJ, PA, VA
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Amalgam Rx, Inc.Ryan A. SyskoRyan A. SyskoPresident and CEO2019-03-05
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A May. 03, 2019 241541: 0001667234-19-000003 Amalgam Rx, Inc.
Offer Amount: $2,000,000
Amount Sold: $1,223,886
Remaining: $776,114
D/A Mar. 05, 2019 241541: 0001667234-19-000002 Amalgam Rx, Inc.
Offer Amount: $2,000,000
Amount Sold: $998,044
Remaining: $1,001,956
D Jun. 30, 2017 241541: 0001667234-17-000003 Amalgam Rx, Inc.
Offer Amount: $2,000,000
Amount Sold: $95,000
Remaining: $1,905,000